FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to cell therapy, and can be used in medicine to repair a damaged myocardium. From the heart of an adult human populations of cells derived from human cardiac tissue are isolated, on the basis of which therapeutic compositions are composed. In addition, the compositions may include an agent selected from: a stem cell factor (CSF), a granulocyte colony-stimulating factor (G-CSF), granulocyte-monocyte colony-stimulating factor (GM-CSF), stromal cell-1 factor, stall factor, vascular endothelial growth factor, macrophage colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and interleukin-3.
EFFECT: invention allows to effectively repair a damaged myocardium.
7 cl, 39 dwg, 20 ex, 30 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CELLS DERIVED FROM CARDIAL TISSUE | 2010 |
|
RU2642282C1 |
| CELLS BEING DERIVATIVES OF CARDIAC TISSUE | 2010 |
|
RU2583287C2 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
| COMPOSITIONS IMPROVING MYOCARDIAL INFARCTION PERFUSION AND METHODS FOR REGENERATION AFTER VASCULAR INJURY | 2013 |
|
RU2550959C2 |
| METHOD FOR OBTAINING AND APPLICATION OF TISSUE ENGINEERING STRUCTURES BASED ON PROGENITAL CELLS FOR HEART DISEASES TREATMENT | 2015 |
|
RU2636464C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
| METHOD FOR PREPARATION AND INDUCTION OF DIRECTIONAL DIFFERENTIATION OF MULTIPOTENT CARDIAC CELL CULTURE FOR CELL-BASED THERAPY AND/OR TISSUE ENGINEERING WITHIN MYOCARDIAL ISCHEMIA | 2008 |
|
RU2366706C1 |
| APPLICATION OF COMPOSITION CONSISTING OF CONCENTRATED CELL POPULATION REPRESENTING STEM CELLS AND UNDIFFERENTIATED PRECURSORS | 2004 |
|
RU2372924C2 |
| METHOD FOR CARDIO-GENERATIVE POTENTIAL DETERMINATION IN MAMMAL CELLS | 2010 |
|
RU2624498C2 |
